A selective aldosterone synthase inhibitor for significantly lowering blood pressure.
Roche
Posted inClinical Trials, Metabolism
Dorzagliatin: Drug That Can “Cure” Diabetes
Hua Medicine has figured out how to bring type 2 diabetes mellitus into long-term and sustained remission.
Posted inAutoimmune Diseases, Clinical Trials, Neuroscience
Ublyxi: Highly Effective Drug for Multiple Sclerosis
Ublituximab is the third anti-CD20 therapy for multiple sclerosis and a worthy rival to Ocrevus and Kesimpta.
Posted inNew Drugs, Oncology, Regulatory
Tivdak: New Drug for Cervical Cancer
Tisotumab vedotin for therapy of previously treated recurrent or metastatic cervical cancer.
Posted inNew Drugs, Regulatory
Vabysmo: New Drug for Wet Age-Related Macular Degeneration and Diabetic Macular Edema
Faricimab by Roche is a strong competitor to Eylea.
Posted inOncology, Research
Tecentriq Plus Avastin: Most Effective Treatment for Unresectable Hepatocellular Carcinoma
Atezolizumab with bevacizumab: a powerful immunotherapy approach for first-line therapy of liver cancer.
Posted inNew Drugs, Regulatory
Susvimo: Pioneering Implant for Treating Wet Age-Related Macular Degeneration
Roche offered a convenient replacement for the traditional Lucentis.